ProteoNova has created the AcPET system, a platform technology with the ability to address both the increasing cost and the increasing timeline for new product development's discovery and pre-clinical stages. This transformative technology will be able to reduce the out-of-pocket cost for each drug candidate to a few million dollars and thetimeline to a few weeks. The cost and time to develop a single protein-based therapeutic, from discovery to FDA submission, is enormous and continues to rise.

ProteoNova

Org chart

Similar companies